The Prevalence and Incidence of HIV Molecular Variants and Their Correlation with Risk Behaviors and HIV Treatment in Brazilian Blood Donors (NHLBI)

ICR 200810-0925-006

OMB: 0925-0597

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
New
Supplementary Document
2009-02-12
Supplementary Document
2009-02-12
Supplementary Document
2009-02-12
Supplementary Document
2009-02-12
Supplementary Document
2009-02-12
Supplementary Document
2009-02-12
Supplementary Document
2009-02-12
Supplementary Document
2009-02-12
Supplementary Document
2009-02-12
Supplementary Document
2008-10-08
Supplementary Document
2008-10-08
Supplementary Document
2008-10-08
Supplementary Document
2008-10-08
Supplementary Document
2008-10-08
Supporting Statement A
2009-02-12
IC Document Collections
IC ID
Document
Title
Status
187011 New
ICR Details
0925-0597 200810-0925-006
Historical Active
HHS/NIH
The Prevalence and Incidence of HIV Molecular Variants and Their Correlation with Risk Behaviors and HIV Treatment in Brazilian Blood Donors (NHLBI)
New collection (Request for a new OMB Control Number)   No
Regular
Approved with change 02/13/2009
Retrieve Notice of Action (NOA) 10/24/2008
Approved consistent with revised documents uploaded on 02/12/2009. OMB understands that the project will be using the basic race and ethnicity categories of the Brazilian Institute of Geography and Statistics (IBGE), rather than the standard OMB categories, given that this study is being carried out exclusively in Brazil.
  Inventory as of this Action Requested Previously Approved
02/29/2012 36 Months From Approved
2,000 0 0
800 0 0
0 0 0

The purpose of the interview questions is to collect donor profile data for comparing risk exposures between prospective blood donors who test HIV positive (cases) and HIV negative (controls). The responses will permit us to determine risk factors associated with HIV infection among volunteer replacement blood donors in Brazil. A case control study will yield interview data on HIV risk behaviors among prospective donors that will be used; 1) to understand predominant risk behaviors associated with in HIV positive blood donation in Brazil, for example: male-to-male sex, having multiple heterosexual partners, and to a lesser extent injection drug use (IDU), 2) the results may also lead to suggestions for modification to current operational donor screening questionnaire in ways that can decrease risk and improve blood safety. The questions for both cases and controls are identical, except for five additional questions that will be asked at the end of the interview on topics that are unique for HIV positive individuals (cases).

US Code: 42 USC 241 Name of Law: Public Health Service Act
  
None

Not associated with rulemaking

  73 FR 30951 05/29/2008
73 FR 46628 08/11/2008
No

1
IC Title Form No. Form Name
HIV Case Control Study 1 survey

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 2,000 0 0 2,000 0 0
Annual Time Burden (Hours) 800 0 0 800 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new information collection request.

$112,132
No
No
Uncollected
Uncollected
Uncollected
Uncollected
Mikia Currie 3014350941

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
10/24/2008


© 2024 OMB.report | Privacy Policy